Anterix (ATEX) Common Equity (2014 - 2026)

Anterix's Common Equity history runs 13 years deep, the most recent figure standing at $262.3 million for Q1 2026.

• Quarterly Common Equity rose 67.51% year-over-year to $262.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262.3 million (up 67.51% YoY) and the FY2026 annual result came in at $262.3 million, up 67.51% from the prior year.
• Common Equity was $262.3 million for Q1 2026 at Anterix, up from $236.0 million in the prior quarter.
• Across five years, Common Equity topped out at $262.3 million in Q1 2026 and bottomed at $139.1 million in Q3 2024.
• A 5-year average of $180.5 million and a median of $174.5 million in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity retreated 22.11% — and 2025, when it soared 72.83%.
• Anterix's Common Equity stood at $159.0 million in 2022, then gained by 8.33% to $172.3 million in 2023, then decreased by 15.97% to $144.7 million in 2024, then surged by 63.01% to $236.0 million in 2025, then advanced by 11.18% to $262.3 million in 2026.
• Business Quant data shows ATEX's Common Equity at $262.3 million in Q1 2026, $236.0 million in Q4 2025, and $240.3 million in Q3 2025.